Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universal Meditech was a medical diagnostics company that manufactured and distributed various in vitro diagnostic test kits. The company's product portfolio included rapid tests for COVID-19, pregnancy, and ovulation, which were marketed under various brand names. In 2023, the company became the subject of intense federal and state investigations after an unlicensed laboratory facility in Reedley, California, was discovered to be storing infectious agents and biohazardous materials. Consequently, the company ceased operations, and the FDA issued recalls for several of its diagnostic products due to a lack of proper clearance and safety concerns.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universal Meditech.